Journal Article

The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-19

Braybrook, Julian, Vandesompele, Jo, Kammel, Martin, In, Jiwon, Storey, Nathaniel, Grunert, Hans-Peter, Verwilt, Jasper, Bae, Young-Kyung, Cowen, Simon, Harris, Kathryn, Hingley-Wilson, Suzie, O’Sullivan, Denise M, Moran-Gilad, Jacob, Foy, Carole A, Hong, Ki Ho, Dühring, Ulf, Huggett, Jim F, Evans, Daniel, Stewart, Graham, Zeichhardt, Heinz

2022

Overview

Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA quantities, measured by reverse transcription quantitative PCR (RT-qPCR), have been proposed to stratify clinical risk or determine analytical performance targets. We investigated reproducibility and how setting diagnostic cutoffs altered the clinical sensitivity of coronavirus disease 2019 (COVID-19) testing. Methods Quantitative SARS-CoV-2 RNA distributions [quantification cycle (Cq) and copies/mL] from more than 6000 patients from 3 clinical laboratories in United Kingdom, Belgium, and the Republic of Korea were analyzed. Impact of Cq cutoffs on clinical sensitivity was assessed. The June/July 2020 INSTAND external quality assessment scheme SARS-CoV-2 materials were used to estimate laboratory reported copies/mL and to estimate the variation in copies/mL for a given Cq. Results When the WHO-suggested Cq cutoff of 25 was applied, the clinical sensitivity dropped to about 16%. Clinical sensitivity also dropped to about 27% when a simulated limit of detection of 106 copies/mL was applied. The interlaboratory variation for a given Cq value was >1000 fold in copies/mL (99% CI). Conclusion While RT-qPCR has been instrumental in the response to COVID-19, we recommend Cq (cycle threshold or crossing point) values not be used to set clinical cutoffs or diagnostic performance targets due to poor interlaboratory reproducibility; calibrated copy-based units (used elsewhere in virology) offer more reproducible alternatives. We also report a phenomenon where diagnostic performance may change relative to the effective reproduction number. Our findings indicate that the disparities between patient populations across time are an important consideration when evaluating or deploying diagnostic tests. This is especially relevant to the emergency situation of an evolving pandemic.

• Publisher: Oxford University Press
• Subject: Belgium / Biological properties / Biological samples / Coronaviruses / COVID-19 / COVID-19 - diagnosis / COVID-19 Nucleic Acid Testing - standards / Diagnostic systems / Humans / Impact analysis / Laboratories / Nucleic acids / Nucleic Acids - analysis / Pandemics / Patients / Quality assessment / Quality control / Reproducibility / Reproducibility of Results / Republic of Korea / Reverse transcription / Ribonucleic acid / Risk analysis / RNA / RNA, Viral - analysis / SARS-CoV-2 / Sensitivity analysis / Sensitivity and Specificity / Severe acute respiratory syndrome coronavirus 2 / United Kingdom / Viral diseases